ArticleCancer immunology, immunotherapy : CII2023

Long-term outcomes of patients with recurrent ovarian cancer treated with a polyvalent vaccine with bevacizumab combination.

Ryan M Kahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.